Massachusetts Eye And Ear Infirmary
Clinical trials sponsored by Massachusetts Eye And Ear Infirmary, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple eye drop stop blindness after retinal detachment? Results expected Sep 2026 (estimated)
- Could a common antibiotic shrink NF2 skin tumors without surgery? Results expected Sep 2026 (estimated)
- Cochlear implant study seeks to cut doctor visits without sacrificing hearing Results expected Nov 2026 (estimated)
- Could a probiotic help save sight in diabetes? Results expected Mar 2027 (estimated)
- New cochlear implant programming aims to sharpen hearing Results expected Mar 2027 (estimated)
-
Experimental drug AR-42 tested on brain tumors – early results uncertain
Disease control Stopped earlyThis early-phase trial tested the drug AR-42 in 7 adults with vestibular schwannoma or meningioma brain tumors who were already scheduled for surgery. Participants took AR-42 pills for about 3 weeks before their operation. The main goal was to see if the drug could lower a protei…
Early phase 1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Glaucoma Drug-Eluting contact lens trial halted after single patient
Disease control Stopped earlyThis study tested a special contact lens that slowly releases the glaucoma drug latanoprost, aiming to replace daily eye drops. Only one person enrolled before the study was stopped early. The goal was to check safety and whether the lens could lower eye pressure, but no conclusi…
Phase 1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC